Last update :
28/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Cefuroxime sodium  
Injection
Eye-drops
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Aksef Turkey
Anaptivan Greece
Aprok Ireland
Aprokam Belgium, Great Britain, Iceland, Turkey
Axetine Romania
Biociclin Italy
Biofuroksyn Poland
Cefofix Saudi Arabia
Cefoprim Italy
Cefurin Italy
Cefurox Argentina
Ceruxim Greece
Curocef Austria
Curoxim Italy
Curoxima Spain
Curoxime Portugal
Duxima Italy
Galemin Greece
Gonif Greece
Ipacef Italy
Itorex Italy
Kefurox Belgium
Keroxime Brazil
Kesint Italy
Lafurex Italy
Multisef Turkey
Nipogalin Greece
Normafenac Greece
Plixym Poland
Prokam Spain
Receant Greece
Supero Italy
Tarsime Poland
Vekfazolin Greece
Ximaract Belgium, Great Britain, Spain
Xorim Poland
Yokel Greece
Zetagal Greece
Zilisten Greece
Zinacef Belgium, Brazil, Canada, Denmark, Finland, Germany, Great Britain, Greece, Netherlands, Norway, Poland, Saudi Arabia, Slovenia, Sweden, Switzerland, United States of America
Zinnat France, Turkey
Zinocep Italy
Stability in solutions   Injection   Stability in solutions : Cefuroxime sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 15 mg/ml 25°C Light
48 Hour
644
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 5 & 10 mg/ml -10°C Protect from light
30 Day
636
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 5 & 10 mg/ml 25°C Not specified
24 Hour
636
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 5 & 10 mg/ml 5°C Protect from light
30 Day
636
Level of evidence B
Glass Sodium chloride 0,9% 7,5 mg/ml 2-8°C Protect from light
7 Day
1452
Level of evidence D
Glass Sodium chloride 0,9% 7,5 mg/ml 25°C Not specified
24 Hour
1452
Level of evidence D
Polyvinyl chloride Water for Injection 22,5 & 45 mg/ml 3°C Protect from light
7 Day
443
Level of evidence B
Polyvinyl chloride Water for Injection 30 & 60 mg/ml -20°C Protect from light
30 Day
443
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 & 10 mg/ml -10°C Protect from light
30 Day
636
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 & 10 mg/ml 25°C Not specified
24 Hour
636
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 & 10 mg/ml 5°C Protect from light
30 Day
636
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 6 mg/ml 25°C Light
24 Hour
1656
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 6 mg/ml 4°C Light
7 Day
1656
Level of evidence B
Polyvinyl chloride Glucose 5% 15 mg/ml -30°C Protect from light
90 Day
1958
Level of evidence D
Polyvinyl chloride Glucose 5% 15 mg/ml 4°C Protect from light
11 Day
656
Level of evidence D
Polyvinyl chloride Glucose 5% 15 mg/ml 4°C Protect from light
15 Day
1958
Level of evidence D
Polyethylene Glucose 5% 15 mg/ml -20°C Protect from light
98 Day
2008
Level of evidence D
Polyethylene Glucose 5% 15 mg/ml 4°C Not specified
31 Day
2095
Level of evidence D
Polyolefine Sodium chloride 0,9% 7,5 mg/ml 2-8°C Protect from light
7 Day
1452
Level of evidence D
Polyolefine Sodium chloride 0,9% 7,5 mg/ml 25°C Not specified
24 Hour
1452
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml -18°C Protect from light
120 Day
3569
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml -20°C Protect from light
365 Day
1972
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
16 Hour
1972
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 5°C Protect from light
21 Day
1972
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml 25°C Not specified
2 Day
1813
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml 5°C Not specified
21 Day
1813
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 90 mg/ml 25°C Protect from light
48 Hour
4284
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 90 mg/ml 4°C Protect from light
14 Day
4284
Level of evidence B
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 5 & 30 mg/ml 4°C Protect from light
10 Day
604
Manufacturer's stability data
AT-Closed vial® Sodium chloride 0,9% 10 mg/ml -20°C Protect from light
365 Day
1972
Level of evidence B
AT-Closed vial® Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
16 Hour
1972
Level of evidence B
AT-Closed vial® Sodium chloride 0,9% 10 mg/ml 5°C Protect from light
21 Day
1972
Level of evidence B
  Mentions Légales